View in EDS HTML Full Text PDF Full Text

Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models.

Saved in:
Bibliographic Details
Title: Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models.
Authors: Li, Shulin1 (AUTHOR), Hoefnagel, Sanne J. M.1,2 (AUTHOR), Read, Matthew3,4 (AUTHOR), Meijer, Sybren5 (AUTHOR), van Berge Henegouwen, Mark I.6 (AUTHOR), Gisbertz, Suzanne S.6 (AUTHOR), Bonora, Elena7 (AUTHOR), Liu, David S. H.8,9 (AUTHOR), Phillips, Wayne A.4,10 (AUTHOR), Calpe, Silvia1 (AUTHOR), Correia, Ana C. P.1 (AUTHOR), Sancho-Serra, Maria D. C.1 (AUTHOR), Mattioli, Sandro7,11 (AUTHOR), Krishnadath, Kausilia K.1,2,12,13 (AUTHOR) Sheila.Krishnadath@uza.be
Source: Cellular Oncology (2211-3428). Aug2022, Vol. 45 Issue 4, p639-658. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:22113428
DOI:10.1007/s13402-022-00689-2